Trupanion (TRUP) Expected to Announce Earnings on Wednesday

Trupanion (NASDAQ:TRUP) is expected to be releasing its earnings data after the market closes on Wednesday, February 19th. Analysts expect Trupanion to post earnings of $0.06 per share and revenue of $335.41 million for the quarter. Persons that wish to register for the company’s earnings conference call can do so using this link.

Trupanion Trading Up 1.2 %

NASDAQ TRUP opened at $49.63 on Tuesday. The firm has a 50 day simple moving average of $48.78 and a 200-day simple moving average of $47.77. The firm has a market cap of $2.10 billion, a price-to-earnings ratio of -155.09, a PEG ratio of 8.03 and a beta of 1.60. Trupanion has a one year low of $19.69 and a one year high of $57.90. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.66 and a current ratio of 1.66.

Insider Transactions at Trupanion

In related news, EVP Steve Weinrauch sold 11,916 shares of the company’s stock in a transaction that occurred on Thursday, November 21st. The stock was sold at an average price of $53.00, for a total transaction of $631,548.00. Following the sale, the executive vice president now directly owns 48,978 shares of the company’s stock, valued at approximately $2,595,834. This represents a 19.57 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CFO Fawwad Qureshi sold 622 shares of the stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $52.61, for a total value of $32,723.42. Following the completion of the sale, the chief financial officer now directly owns 9,867 shares in the company, valued at $519,102.87. This represents a 5.93 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 26,597 shares of company stock worth $1,416,742. 5.50% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on the stock. Piper Sandler upgraded shares of Trupanion from a “neutral” rating to an “overweight” rating and set a $57.00 target price on the stock in a research report on Thursday, January 23rd. Stifel Nicolaus boosted their target price on shares of Trupanion from $42.00 to $44.00 and gave the stock a “hold” rating in a research report on Monday, January 6th. Finally, Northland Securities lifted their price target on Trupanion from $45.00 to $50.00 and gave the stock a “market perform” rating in a research note on Thursday, October 31st. Two equities research analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $45.33.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.